323 related articles for article (PubMed ID: 33671315)
1. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315
[TBL] [Abstract][Full Text] [Related]
2. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
Rodrigo C; Fernando SD; Rajapakse S
Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
Eze P; Mezue KN; Nduka CU; Obianyo I; Egbuche O
Am J Cardiovasc Dis; 2021; 11(1):93-107. PubMed ID: 33815925
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P
J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis.
Agstam S; Yadav A; Kumar-M P; Gupta A
Indian Pacing Electrophysiol J; 2021; 21(1):36-43. PubMed ID: 33075484
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN
Front Pharmacol; 2020; 11():562777. PubMed ID: 33154723
[TBL] [Abstract][Full Text] [Related]
9. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.
Gagnon LR; Sadasivan C; Yogasundaram H; Oudit GY
Curr Heart Fail Rep; 2022 Dec; 19(6):458-466. PubMed ID: 36167917
[TBL] [Abstract][Full Text] [Related]
10. Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use.
Chen Y; Shen T; Zhong L; Liu Z; Dong X; Huang T; Wang Q; Xiao H
Front Pharmacol; 2020; 11():1167. PubMed ID: 32848774
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis.
Tleyjeh IM; Kashour Z; AlDosary O; Riaz M; Tlayjeh H; Garbati MA; Tleyjeh R; Al-Mallah MH; Sohail MR; Gerberi D; Bin Abdulhak AA; Giudicessi JR; Ackerman MJ; Kashour T
Mayo Clin Proc Innov Qual Outcomes; 2021 Feb; 5(1):137-150. PubMed ID: 33163895
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review.
Acharya Y; Sayed A
Ther Adv Infect Dis; 2020; 7():2049936120947517. PubMed ID: 32821381
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19.
Mittal N; Mittal R; Gupta MC; Kaushal J; Chugh A; Khera D; Singh S
J Family Med Prim Care; 2021 Jun; 10(6):2126-2139. PubMed ID: 34322403
[TBL] [Abstract][Full Text] [Related]
14. Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).
Zhao Y; Zhang J; Zheng K; Thai S; Simpson RJ; Kinlaw AC; Xu Y; Wei J; Cui X; Buse JB; Stürmer T; Wang T
Drugs Real World Outcomes; 2022 Jun; 9(2):231-241. PubMed ID: 35386046
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of ECG testing and characteristics among new hydroxychloroquine and chloroquine users within a multi-center tertiary care center.
Choi MY; Weber B; Stevens E; Guan H; Ellrodt J; Oakes E; Di Carli M; Tedrow U; Sauer W; Costenbader KH
Rheumatol Int; 2022 Oct; 42(10):1767-1774. PubMed ID: 35430712
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN
medRxiv; 2020 May; ():. PubMed ID: 32511539
[TBL] [Abstract][Full Text] [Related]
18. QT interval and repolarization dispersion changes during the administration of hydroxychloroquine/chloroquine with/without azithromycin in early COVID 19 pandemic: A prospective observational study from two academic hospitals in Indonesia.
Gumilang RA; Siswanto ; Anggraeni VY; Trisnawati I; Budiono E; Hartopo AB
J Arrhythm; 2021 Oct; 37(5):1184-1195. PubMed ID: 34621417
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions.
Souza Botelho M; Bolfi F; Leite RGOF; Leite MSF; Banzato LR; Soares LT; Olivatti TOF; Mangolim AS; Oliveira FRK; Abbade LPF; Abbade JF; de Barros Almeida RAM; Simões Corrêa Galendi J; Thabane L; Dos Santos Nunes-Nogueira V
Syst Rev; 2021 Nov; 10(1):294. PubMed ID: 34736537
[TBL] [Abstract][Full Text] [Related]
20. Effects of chloroquine or hydroxychloroquine treatment on non-SARS-CoV2 viral infections: A systematic review of clinical studies.
Cui X; Sun J; Minkove SJ; Li Y; Cooper D; Couse Z; Eichacker PQ; Torabi-Parizi P
Rev Med Virol; 2021 Nov; 31(6):e2228. PubMed ID: 33694220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
